{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:16:01Z","timestamp":1792707361965,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,27]]},"DOI":"10.1097\/01.tp.0000092496.05951.d5","type":"journal-article","created":{"date-parts":[[2003,12,23]],"date-time":"2003-12-23T04:05:23Z","timestamp":1072152323000},"page":"1742-1749","source":"Crossref","is-referenced-by-count":49,"title":["Tumour necrosis factor receptor type II 196M\/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation1"],"prefix":"10.1097","volume":"76","author":[{"given":"Gail L.","family":"Stark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham H.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope R.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Socie","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199708270-00001","article-title":"Cytokine cascades in acute graft-versus-host disease","volume":"64","author":"Krenger","year":"1997","journal-title":"Transplantation"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1016\/S0021-9258(18)63791-3","article-title":"Two different cell types have different major receptors for human tumor necrosis factor (TNF-alpha)","volume":"264","author":"Hohmann","year":"1989","journal-title":"J Biol Chem"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/j.1460-2075.1994.tb06327.x","article-title":"Dissociation of the TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants","volume":"13","author":"Barbara","year":"1994","journal-title":"EMBO J"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/377348a0","article-title":"Induction of apoptosis in mature T cells by tumor necrosis factor","volume":"377","author":"Zheng","year":"1995","journal-title":"Nature"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"MacEwan","year":"2002","journal-title":"Cell Signal"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"18542","DOI":"10.1016\/S0021-9258(17)46661-0","article-title":"Ligand passing: the 75 kDa tumor necrosis factor (TNF) receptor recruits TNF for signalling by the 55kDa TNF receptor","volume":"268","author":"Tartaglia","year":"1993","journal-title":"J Biol Chem"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1073\/pnas.95.25.14875","article-title":"A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families","volume":"95","author":"Gaffney","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1399-0039.1999.530602.x","article-title":"Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus","volume":"53","author":"Komata","year":"1999","journal-title":"Tissue Antigens"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2","article-title":"Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese","volume":"44","author":"Morita","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-0039.2001.057001066.x","article-title":"Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese","volume":"57","author":"Takahashi","year":"2001","journal-title":"Tissue Antigens"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0198-8859(01)00280-4","article-title":"Tumor necrosis factor receptor 2 polymorphism in systemic lupus erythematosus: no association with disease","volume":"62","author":"Lee","year":"2001","journal-title":"Hum Immunol"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0039.2000.550122.x","article-title":"Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus","volume":"55","author":"Al-Ansari","year":"1999","journal-title":"Tissue Antigens"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q","article-title":"Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians","volume":"44","author":"Barton","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.bmt.1703409","article-title":"Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation","volume":"29","author":"Ishikawa","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V98.5.1594","article-title":"Interferon-gamma and interleukin-6 polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation","volume":"98","author":"Cavet","year":"2001","journal-title":"Blood"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00007890-200108270-00024","article-title":"Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hemopoietic stem cell transplantation","volume":"72","author":"Socie","year":"2001","journal-title":"Transplantation"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V94.11.3941","article-title":"Recipient tumour necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants","volume":"94","author":"Cavet","year":"1999","journal-title":"Blood"},{"key":"R19-16-20210129","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bmt.1702724","article-title":"Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-haemopoietic stem cell transplantation","volume":"26","author":"Takahashi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2141.2001.02811.x","article-title":"Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants","volume":"113","author":"Cullup","year":"2001","journal-title":"Br J Haematol"},{"key":"R21-16-20210129","first-page":"323","article-title":"Skin explant culture as a model for cutaneous graft-versus-host disease in humans","volume":"3","author":"Dickinson","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"R22-16-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"R23-16-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R24-16-20210129","first-page":"247","article-title":"Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease","volume":"4","author":"Atkinson","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"R25-16-20210129","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"key":"R26-16-20210129","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumour necrosis factor receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"R27-16-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nm0602-575","article-title":"Acute graft-versus-host disease does not require alloantigen expression on host epithelium","volume":"8","author":"Teshima","year":"2002","journal-title":"Nat Med"},{"key":"R28-16-20210129","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJM200011303432201","article-title":"A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis","volume":"343","author":"Bathon","year":"2000","journal-title":"N Engl J Med"},{"key":"R29-16-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007890-200202270-00035","article-title":"Recombinant human tumor necrosis factor receptor fusion protein as complimentary treatment for chronic graft-versus-host disease","volume":"73","author":"Chiang","year":"2002","journal-title":"Transplantation"},{"key":"R30-16-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art1.10243","article-title":"Experience with etanercept in an academic medical center: are infection rates increased?","volume":"47","author":"Philips","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.TP.0000092496.05951.D5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:59:39Z","timestamp":1785783579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200312270-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,27]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000092496.05951.d5","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12,27]]}}}